Health-related quality of life for frail transplant-ineligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone: Subgroup analysis of MAIA Trial Meeting Abstract


Authors: Perrot, A.; Facon, T.; Plesner, T.; Usmani, S.; Kumar, S. K.; Bahlis, N. J.; Hulin, C.; Orlowski, R. Z.; Nahi, H.; Mollee, P.; Ramasamy, K.; Roussel, M.; Jaccard, A.; Delforge, M.; Karlin, L.; Arnulf, B.; Chari, A.; Pei, H.; Gupta, N.; Kaila, S.; Matt, K.; Gries, K. S.; Carson, R.; Borgsten, F.; Weisel, K.
Abstract Title: Health-related quality of life for frail transplant-ineligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone: Subgroup analysis of MAIA Trial
Meeting Title: 64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 140
Issue: Suppl. 1
Meeting Dates: 2022 Dec 10-13
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-11-15
Start Page: 1142
End Page: 1145
Language: English
ACCESSION: WOS:000893223201058
DOI: 10.1182/blood-2022-165524
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Saad Zafar Usmani
    300 Usmani